These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3077201)

  • 41. Natural history of glucose intolerance in obesity. A ten year observation.
    Toeller M; Gries FA; Dannehl K
    Int J Obes; 1982; 6 Suppl 1():145-9. PubMed ID: 6749720
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA; Goodman AM
    N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity.
    Kosaka K; Kuzuya T; Yoshinaga H; Hagura R
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S120-6. PubMed ID: 8894495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluoxetine therapy in obese diabetic and glucose intolerant patients.
    Kutnowski M; Daubresse JC; Friedman H; Kolanowski J; Krzentowski G; Scheen A; Van Gaal L
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S63-6. PubMed ID: 1338388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of glucose intolerance in obese (fa/fa) Zucker rats.
    Apweiler R; Freund P
    Horm Metab Res; 1993 Oct; 25(10):521-4. PubMed ID: 8262460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.
    Shiraishi I; Iwamoto Y; Kuzuya T; Matsuda A; Kumakura S
    Diabetologia; 1991 Oct; 34(10):737-41. PubMed ID: 1959706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of fructosamine, glycosylated hemoglobin and glucose in patients with type II diabetes].
    Tvorogova MG; Zaĭtseva TM; Aronskaia EE; Kozlov SG; Sharipova GKh; Titov VN
    Klin Lab Diagn; 1995; (1):10-2. PubMed ID: 7757352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycosylated hemoglobin monitoring of diabetic patients: a pilot study and case report.
    Stathopoulos PC
    J Manipulative Physiol Ther; 1984 Mar; 7(1):51-5. PubMed ID: 6716018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenic factors responsible for glucose intolerance in patients with NIDDM.
    Taniguchi A; Nakai Y; Fukushima M; Kawamura H; Imura H; Nagata I; Tokuyama K
    Diabetes; 1992 Dec; 41(12):1540-6. PubMed ID: 1446794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative contribution of insulin secretion and sensitivity at different stages of glucose tolerance: non-obese versus obese Japanese subjects.
    Iwao T; Sakai K; Ando E
    Intern Med; 2014; 53(5):383-90. PubMed ID: 24583424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous blood glucose measurement and insulin levels in subjects with ideal body weight, normal body weight, non-diabetic overweight and obese subjects with impaired glucose tolerance.
    Dolderer M; De la Fuente A; Kerner W; Zier H; Pfeiffer EF
    Horm Metab Res Suppl; 1992; 26():24-7. PubMed ID: 1490688
    [No Abstract]   [Full Text] [Related]  

  • 53. Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes.
    Fizelova M; Stančáková A; Lorenzo C; Haffner SM; Cederberg H; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2015 May; 100(5):1989-96. PubMed ID: 25734252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demonstration of heterogeneity in gestational diabetes by a 400-kcal breakfast meal tolerance test.
    Cheney C; Shragg P; Hollingsworth D
    Obstet Gynecol; 1985 Jan; 65(1):17-23. PubMed ID: 3880878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycosylated hemoglobin (HbA1), glucose tolerance and neonatal outcome in gestational diabetic and non-diabetic mothers.
    Bacigalupo G; Langner K; Saling E
    J Perinat Med; 1984; 12(3):137-45. PubMed ID: 6502440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral glucose tolerance: relationship with hemoglobin A1c.
    Starkman HS; Soeldner JS; Gleason RE
    Diabetes Res Clin Pract; 1987; 3(6):343-9. PubMed ID: 3311681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A combination of glycosylated hemoglobin and fasting plasma glucose testing facilitate screening of diabetes mellitus].
    Nunoi K
    Fukuoka Igaku Zasshi; 1984 May; 75(5):271-82. PubMed ID: 6489908
    [No Abstract]   [Full Text] [Related]  

  • 58. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance.
    Modan M; Halkin H; Karasik A; Lusky A
    Am J Epidemiol; 1984 Mar; 119(3):431-44. PubMed ID: 6702817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of glycosylated hemoglobin with the oral glucose tolerance test. A study in subjects with normoglycemia, glucose intolerance and non-insulin-dependent diabetes mellitus.
    Cederholm J; Ronquist G; Wibell L
    Diabete Metab; 1984 Oct; 10(4):224-9. PubMed ID: 6510543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosylated proteins in patients with insulinoma.
    Hale PJ; Turner GN; Nattrass M
    Ann Clin Biochem; 1988 Jul; 25 ( Pt 4)():440-1. PubMed ID: 2850762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.